Our assets
Alfa Intes Industria Terapautica Splendore is vertically integrated in all the activities of pharmaceutical value-chain for marketing of a wide range of medicinal products, medical devices and nutraceuticals indicated for a multitude of eye-care diseases and dysfunctions.
The Alfa Intes commitment is addresses to each of these activities for the sole purpose to provide high quality and innovative solutions for the patient and all helathcare providers involved in the ophthalmolgical segment.
I nostri punti di forza possono essere riassunti in ciasuna delle attività riportate di seguito:
The Alfa Intes commitment is addresses to each of these activities for the sole purpose to provide high quality and innovative solutions for the patient and all helathcare providers involved in the ophthalmolgical segment.
I nostri punti di forza possono essere riassunti in ciasuna delle attività riportate di seguito:
ManufacturingAlfa Intes disposes of state of art manufacturing implants which comply with the principles of Good Manufacturing Practice to achieve the requisite quality and be in accordance with the most stringent manufacturing authorizations. Its fully automated production lines and top-class cleaning rooms technology are certified, regularly inspected and approved by the top national and international regulatory bodies. The accuracy, reproducibility and compliance of the wide range of Alfa Intes owned products are granted by the highest quality standards.
|
|
Quality assuranceQuality in pharma industry is essential. Alfa Intes commitment to a comprehensively designed and correctly implemented system of Quality Assurance is pivotal to its business. To ensure that all its products are fit for their intended Alfa Intes disposes of the latest sophisticated instruments for manufacturing diagnostic and laboratory equipment, all fully supported by approved GMP general and specific documentations procedures, trained personnel and a wide range of national and regional accreditations.
|
|
Research & DEVELOPMENT
|
The longevity of Alfa Intes is based on its ability to adapt its product portfolio to the changing market environment and demanding consumer needs. Developing and exploiting technological processes and therapeutic innovations are the main sources of competition for Alfa Intes. Open-source research models have the potential to democratize innovation and discovery by linking together academia, industry, government agencies, philanthropic organizations, NGOs, private investors and individuals across the globe. Creating innovative treatments, drugs and formulations as part of training and education for pharmacologists, doctors and researchers from scientific academies and universities is the standard process for every research-based practice activity in Alfa Intes.
|
|
formationThe Alfa Intes concern for patient wellbeing reinforced the company commitment for professional learning to support practitioners in the early stage of training to develop the basic knowledge and skill required for a physician via modern communication channels in a flexible, accessible way. Alfa Intes schedules at national and local level, stages, webinars, seminars and advanced formation courses for every attendee qualified to medical profession, by implying more than 750 italian ophthalmologists, for a total amount of 1350 formation days.
|
|
